Netherlands· NL-ff1bcbfbd6a1
Lercanidipine Accord 10 mg filmomhulde tabletten
A lercanidipine product containing lercanidipinehydrochloride, registered in Netherlands by Accord Healthcare B.V.. The same ATC class is registered in 16 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Lercanidipine is registered in 16 of 19 countries.
Countries holding a registration under ATC C08CA13 (lercanidipine), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 10 of them publish a price we can compare per daily dose
Lercanidipine · ATC C08CA13
16 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of lercanidipine costs, country by country.
Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.14 in France to $0.36 in Switzerland — a ×2.6 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Lercanidipine · price per daily dose (10 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.36
- ES Spain$0.25
- IT Italy$0.21
- FR France$0.14
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- LERCANIDIPINEHYDROCHLORIDE
- Manufacturer
- Accord Healthcare B.V.
- Country
- Netherlands (NL)
- ATC code
- C08CA13
- ATC class
- Lercanidipine
- Defined daily dose
- 10 mg, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id127235
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
2 interactions on record for lercanidipine.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Lercanidipine · interactions on record
2 records
2 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Lercanidipine in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaJOSPITENEgis Pharmaceuticals PLC, Budapešť
- PolandJospitenEgis Pharmaceuticals PLC
- SpainLERCADIP 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULACasen Recordati S.L.
- ItalyAYRDOZELIADAY ZERO EHF
- FranceLERCAN 10 mg, comprimé pelliculé sécableBOUCHARA-RECORDATI
- BelgiumEnalapril/Lercanidipin Sandoz 10 mg - 10 mgSandoz
- SwitzerlandLercanidipin axapharm
- FinlandLercamedOmet Pharma AB
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Lercanidipin Accord, Lercanidipin Actavis
- Belgium · Lercanidipin Sandoz, Lercanidipine Ab
- Bulgaria · Areta, Арета
- Cyprus · Zanedip
- Czechia · Jospiten, Kapidin
- Germany · Carmen, Corifeo
- Denmark · Lercanidipine, Lercanidipine Accord
- Estonia · Lercanidipine Accord, Lercanidipine Actavis
- Spain · Lercadip, Lercanidipino Aurovitas Spain
- Finland · Lercamed, Lercanidipin Hydrochlorid Actavis
- France · Lercan, Lercanidipine Accord
- United Kingdom (Northern Ireland) · Lercanidipine Generics [uk], Lercanidipine Hcl Recordati Industria Chimica E Farmaceutica S.P.A.
- Greece · Lercadip, Zanidip
- Croatia · Lercanil, Pinox
- Hungary · Kapidin, Lecalpin
- Ireland · Lecalpin, Lercanidipine Clonmel
- Iceland · Lercanidipin Actavis, Lerkanidipin Actavis
- Italy · Cardiovasc, Lercadip
- Lithuania · Lercanidipine Actavis, Lercanidipine Ingen Pharma
- Luxembourg · Lercanidipine Eg, Zanidip
- Latvia · Kapidin, Lercanidipine Accord
- Malta · Lercanidipine Torrent
- Norway · Lercanidipine Accord, Lercanidipine Orion
- Poland · Jospiten, Kapizen
- Portugal · Lercanidipina Alter, Lercanidipina Atral
- Romania · Lercanidipină Gemax Pharma, Leridip
- Sweden · Lercamed, Lercanidipine Accord
- Slovenia · Lecalpin, Lercapress
- Slovakia · Kapidin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/aff6630b-7d16-4dfb-bc9c-15ec3af8abfa GET /v1/drugs/aff6630b-7d16-4dfb-bc9c-15ec3af8abfa?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Filmomhulde tablet",
"route": "Oraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h127235_smpc.pdf",
"strength": null,
"atc_label": "Lercanidipine",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg127235",
"excipients": [
"CELLULOSE, MICROKRISTALLIJN (E 460(i))",
"IJZEROXIDE GEEL (E 172)",
"LACTOSE 1-WATER",
"MACROGOL",
"MAGNESIUMSTEARAAT (E 470b)",
"NATRIUMZETMEELGLYCOLAAT",
"POLYVINYLALCOHOL, GEDEELTELIJK GEHYDROLYSEERD (E1203)",
"POVIDON K 30 (E 1201)",
"TALK (E 553b)",
"TITAANDIOXIDE (E 171)"
],
"substances": [
"LERCANIDIPINEHYDROCHLORIDE"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h127235.pdf",
"authorised_at": "2022/05/27",
"procedure_number": "FI/H/1096/001",
"dispensing_status": "Uitsluitend recept",
"registration_number": "127235",
"additional_monitoring": "N"
}See everything about lercanidipine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.